Dermapharm Holding SE (FRA:DMP) Short Interest


FRA:DMP Dermapharm Holding SE FRA:DMP
87 GF Score
Price €46.25
GF Value €39.11
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Dermapharm Holding SE Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:DMP vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dermapharm Holding SE Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's Short Interest distribution charts can be found below:

* The bar in red indicates where Dermapharm Holding SE's Short Interest falls into.


FRA:DMP
87GF Score
Dermapharm Holding SE FRA:DMP
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dermapharm Holding SE (FRA:DMP) Overvalued in 2026?

Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued. The current stock price of €46.25 is trading 18.3% above its estimated GF Value™ of €39.11. GuruFocus considers Dermapharm Holding SE to be Modestly Overvalued.

Key valuation signals for FRA:DMP:

  • Short Interest:
  • GF Value™: €39.11 vs. price of €46.25 (18.3% above fair value)
  • GF Score™: 87/100 with 9 warning signs

No single metric tells the full story. See the FRA:DMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dermapharm Holding SE Business Description

Address Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
87GF Score

Get the complete analysis for FRA:DMP

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.25
Price
€39.11
GF Value